Inflammation & Allergy - Drug Targets (Discontinued)
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 2
Author(s): Dolores Pérez-Sala
Affiliation:
Export Options
About this article
Cite this article as:
Pérez-Sala Dolores, Meet Our Editorial Board Member, Inflammation & Allergy - Drug Targets (Discontinued) 2015; 14 (2) . https://dx.doi.org/10.2174/187152811402160416002648
DOI https://dx.doi.org/10.2174/187152811402160416002648 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
26
Related Articles
-
Platelets as Potential Link Between Diabetes and Alzheimer's Disease
Current Alzheimer Research Endothelial Therapy of Atherosclerosis and its Risk Factors
Current Vascular Pharmacology The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews Synthesis and Biological Evaluation of New Tyrosol-Salicylate Derivatives as Potential Anti-Inflammatory Agents
Current Pharmaceutical Design Lock Stock and Barrel of Wound Healing
Current Pharmaceutical Design Eotaxin Receptor (CCR3) Antagonism in Asthma and Allergic Disease
Current Drug Targets - Inflammation & Allergy The Treatment of Autoimmune Hepatitis
Current Clinical Pharmacology Hydrolases in Organic Chemistry. Recent Achievements in the Synthesis of Pharmaceuticals
Current Organic Chemistry A Merger of Rational Drug Design and Combinatorial Chemistry Development and Application of Peptide Secondary Structure Mimetics
Combinatorial Chemistry & High Throughput Screening Editorial (Hot Topic: Glial Proteins and Peptides: Implications in Neuroinflammation)
Current Protein & Peptide Science Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets
Current Drug Targets Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling
Current Neuropharmacology Novel Strategies and Model Studies for Colon Targeted Drug Delivery
Drug Delivery Letters The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Addressing Alzheimers Disease Tangles: From NAP to AL-108
Current Alzheimer Research Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Current Pharmaceutical Design Kidney Diseases and Chemokines
Current Drug Targets Discovery and Development of Hepatitis C Virus Inhibitors Targeting the NS5A Protein
Mini-Reviews in Medicinal Chemistry Anabolic Factors in Degenerative Joint Disease
Current Drug Targets